Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
SEDDS: Improving Oral Bioavailability Of Poorly Soluble Compounds
Nearly 90% of marketed drugs have poor water solubility. Learn how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.
-
Extraction And Chemical Characterization Pitfalls In Complex Medical Devices
Standard extraction protocols routinely fail tissue-derived products, hydrogels, absorbables, and silicone implants. Learn the material-specific study design strategies that prevent regulatory rejection and repeat work.
-
The Bioprocessing Industry Has A Digital Execution Problem
Digital execution remains a major barrier in manufacturing. Learn how fragmented data, manual decisions, and inconsistent adoption affect the ability to bring complex therapies to patients faster.
-
How Can Biopharma Overcome Digital Transformation Failure?
Biopharma understands the promise of digital transformation, but implementation remains the challenge. Learn why organizational structures must evolve to turn strategies into scalable results.
-
Ophthalmic Drug Delivery: Meeting Modern Challenges With A Next Generation Solution
Ophthalmic injectable packaging demands early strategic attention. Learn how silicone oil contamination, particulate limits, and dosing accuracy challenges can derail development programs and what it takes to stay compliant.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Evaluating Clone Performance And Cell-Specific Productivity
See how continuous process monitoring and automated at-line analytics support confident CHO clone ranking, consistent cultivation, and scale-up by connecting pH, viable cell density, and more.
-
A Comparison To Traditional Clone Screening Platforms
See how 46 CHO clones performed across automated, deep-well, and microbioreactor fed-batch cultures, using cell density, viability, and IgG concentration to evaluate clone performance.
-
A Sensory Panel Study With The Focus On High-Intensity Sweeteners
Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.
-
Characterizing mRNA Using Ion-Pairing Reversed-Phase LC/MS
mRNA poly(A) tail analysis depends on targeted digestion, clean LC/MS conditions, and reliable deconvolution. See how RNase 4 digestion and optimized ion-pairing methods support reproducible results.
-
Effect Of Column Chemistry On The Separation Of GLP-1 Peptides
Small changes in mobile phase, temperature, and column chemistry can affect the detection of GLP-1 peptide impurities. Learn which conditions improve resolution for challenging peptide analyses.
FORMULATION DEVELOPMENT SOLUTIONS
- An Alternative Suitable For High-Risk Applications
- Accelerate Molecules Through Development With Translational Pharmaceutics®
- Largest Global Network Of Harmonized GMP Product Testing Laboratories
- R&D And Analytical Services
- Psychedelics: Drug Development Capabilities
- Accelerating FIH Trials To POC With Speed, Safety, And Certainty
- Adare Pharma Solutions (APS) Orbis Overview
- A Revolutionary Consumable Empowering High-Throughput Organ-Chip Studies
- Leading The Way In Rapid Quantitation Of Host Cell DNA
- Automated Cell Imaging System
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- METTLER TOLEDO Introduces LightningBuild Program For Four-Week Delivery
- Eurofins CDMO Alphora Expands Kilolab And High Potency Development And Manufacturing Capabilities
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Project Farma Acquires SimoTech To Expand Life Sciences Manufacturing Services
- Bristol Myers Squibb Selects Houston For Major $2.3B Manufacturing Investment
- Harro Höfliger Expands European Footprint With New France Subsidiary